276 related articles for article (PubMed ID: 16782889)
21. Oxidative burden and mitochondrial dysfunction in a mouse model of Rett syndrome.
Grosser E; Hirt U; Janc OA; Menzfeld C; Fischer M; Kempkes B; Vogelgesang S; Manzke TU; Opitz L; Salinas-Riester G; Müller M
Neurobiol Dis; 2012 Oct; 48(1):102-14. PubMed ID: 22750529
[TBL] [Abstract][Full Text] [Related]
22. Metabolomic Fingerprint of Mecp2-Deficient Mouse Cortex: Evidence for a Pronounced Multi-Facetted Metabolic Component in Rett Syndrome.
Golubiani G; Lagani V; Solomonia R; Müller M
Cells; 2021 Sep; 10(9):. PubMed ID: 34572143
[TBL] [Abstract][Full Text] [Related]
23. The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome.
Miyake K; Hirasawa T; Soutome M; Itoh M; Goto Y; Endoh K; Takahashi K; Kudo S; Nakagawa T; Yokoi S; Taira T; Inazawa J; Kubota T
BMC Neurosci; 2011 Aug; 12():81. PubMed ID: 21824415
[TBL] [Abstract][Full Text] [Related]
24. Modulation of Rho GTPases rescues brain mitochondrial dysfunction, cognitive deficits and aberrant synaptic plasticity in female mice modeling Rett syndrome.
De Filippis B; Valenti D; Chiodi V; Ferrante A; de Bari L; Fiorentini C; Domenici MR; Ricceri L; Vacca RA; Fabbri A; Laviola G
Eur Neuropsychopharmacol; 2015 Jun; 25(6):889-901. PubMed ID: 25890884
[TBL] [Abstract][Full Text] [Related]
25. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
Pejhan S; Rastegar M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
[TBL] [Abstract][Full Text] [Related]
26. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
Yang W; Pan H
Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
[TBL] [Abstract][Full Text] [Related]
27. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.
Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME
Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136
[TBL] [Abstract][Full Text] [Related]
28. Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome.
Okabe Y; Takahashi T; Mitsumasu C; Kosai K; Tanaka E; Matsuishi T
PLoS One; 2012; 7(4):e35354. PubMed ID: 22532851
[TBL] [Abstract][Full Text] [Related]
29. Exclusive expression of MeCP2 in the nervous system distinguishes between brain and peripheral Rett syndrome-like phenotypes.
Ross PD; Guy J; Selfridge J; Kamal B; Bahey N; Tanner KE; Gillingwater TH; Jones RA; Loughrey CM; McCarroll CS; Bailey ME; Bird A; Cobb S
Hum Mol Genet; 2016 Oct; 25(20):4389-4404. PubMed ID: 28173151
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial dysfunction in the skeletal muscle of a mouse model of Rett syndrome (RTT): implications for the disease phenotype.
Gold WA; Williamson SL; Kaur S; Hargreaves IP; Land JM; Pelka GJ; Tam PP; Christodoulou J
Mitochondrion; 2014 Mar; 15():10-7. PubMed ID: 24613463
[TBL] [Abstract][Full Text] [Related]
31. The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndrome.
Brown K; Selfridge J; Lagger S; Connelly J; De Sousa D; Kerr A; Webb S; Guy J; Merusi C; Koerner MV; Bird A
Hum Mol Genet; 2016 Feb; 25(3):558-70. PubMed ID: 26647311
[TBL] [Abstract][Full Text] [Related]
32. Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients.
Lilja T; Wallenborg K; Björkman K; Albåge M; Eriksson M; Lagercrantz H; Rohdin M; Hermanson O
Epigenetics; 2013 Mar; 8(3):246-51. PubMed ID: 23348913
[TBL] [Abstract][Full Text] [Related]
33. Acquired microcephaly, regression of milestones, mitochondrial dysfunction, and episodic rigidity in a 46,XY male with a de novo MECP2 gene mutation.
Condie J; Goldstein J; Wainwright MS
J Child Neurol; 2010 May; 25(5):633-6. PubMed ID: 20142466
[TBL] [Abstract][Full Text] [Related]
34. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
[TBL] [Abstract][Full Text] [Related]
35. Radically truncated MeCP2 rescues Rett syndrome-like neurological defects.
Tillotson R; Selfridge J; Koerner MV; Gadalla KKE; Guy J; De Sousa D; Hector RD; Cobb SR; Bird A
Nature; 2017 Oct; 550(7676):398-401. PubMed ID: 29019980
[TBL] [Abstract][Full Text] [Related]
36. MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome.
Tai DJ; Liu YC; Hsu WL; Ma YL; Cheng SJ; Liu SY; Lee EH
Nat Commun; 2016 Feb; 7():10552. PubMed ID: 26842955
[TBL] [Abstract][Full Text] [Related]
37. Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism.
Swanberg SE; Nagarajan RP; Peddada S; Yasui DH; LaSalle JM
Hum Mol Genet; 2009 Feb; 18(3):525-34. PubMed ID: 19000991
[TBL] [Abstract][Full Text] [Related]
38. The story of Rett syndrome: from clinic to neurobiology.
Chahrour M; Zoghbi HY
Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
[TBL] [Abstract][Full Text] [Related]
39. A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome.
Matagne V; Ehinger Y; Saidi L; Borges-Correia A; Barkats M; Bartoli M; Villard L; Roux JC
Neurobiol Dis; 2017 Mar; 99():1-11. PubMed ID: 27974239
[TBL] [Abstract][Full Text] [Related]
40. Activity-dependent aberrations in gene expression and alternative splicing in a mouse model of Rett syndrome.
Osenberg S; Karten A; Sun J; Li J; Charkowick S; Felice CA; Kritzer M; Nguyen MVC; Yu P; Ballas N
Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5363-E5372. PubMed ID: 29769330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
